1. OC.12.1 SPOSIB SB2 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2. (1st October 2020) Authors: Macaluso, F.S.; Fries, W.; Viola, A.; Centritto, A.; Cappello, M.; Giuffrida, E.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Vinci, E.; Vassallo, R.; Trovatello, A.; Belluardo, N.; Giangreco, E.; Camilleri, S.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Renna, S.; Orlando, R. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS. (25th March 2019) Authors: Macaluso, F.S.; Cappello, M.; Giuffrida, E.; Fries, W.; Centritto, A.; Privitera, A.C.; Inserra, G.; Vassallo, R.; Magnano, A.; Vinci, E.; Garufi, S.; Ventimiglia, M.; Renna, S.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T04.01.19 USTEKINUMAB IN CROHN'S DISEASE: REAL-WORLD OUTCOMES FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) – PRELIMINARY RESULTS. (1st October 2020) Authors: Centritto, A.; Fiocco, G.; Alibrandi, A.; Macaluso, F.S.; Cappello, M.; Privitera, A.C.; Magri, G.; Ferracane, C.; Garufi, S.; Viola, A.; Giuffrida, E.; Costantino, G.; Ventimiglia, M.; Renna, S.; Orlando, A.; Fries, W. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗